TNF-α and IFN-γ treatment of BPH-1 cells significantly increased the expression of cyclin D1, cyclin D2, and CDK4 compared to that in the untreated group (Fig. 8F-8I). The gene discussed is CCND2; the disease is benign prostatic hyperplasia.